Clinical Trial Update: To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN060 in ESRD Dialysis Patients [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of KN060 in end-stage renal disease patients requiring haemodialysis. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• KN060

Snippet

Sponsor: Suzhou Alphamab Co., Ltd. | Conditions: End-Stage Renal Disease Requiring Haemodialysis | Phase 1, Phase 2 | Status: RECRUITING